Dual Antiplatelet Therapy in Coronary Artery Disease
Abstract Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. While prasugrel demonstra...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Adis, Springer Healthcare
2020-08-01
|
| Ráidu: | Cardiology and Therapy |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1007/s40119-020-00197-0 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|